Stonehage Fleming (UK)’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-206
Closed -$19K 313
2014
Q4
$19K Buy
206
+101
+96% +$9.32K 0.01% 262
2014
Q3
$7K Sell
105
-200
-66% -$13.3K ﹤0.01% 305
2014
Q2
$32K Sell
305
-170
-36% -$17.8K 0.01% 206
2014
Q1
$39K Buy
+475
New +$39K 0.02% 272